Related Experiment Video
Updated: Jul 20, 2026

Bioluminescence and Near-infrared Imaging of Optic Neuritis and Brain Inflammation in the EAE Model of Multiple Sclerosis in Mice
Published on: March 1, 2017
A Case of Neuromyelitis Optica Spectrum Disorder With Improvement in Urinary Retention After the Administration of
Takuya Saito1, Tatsuhito Ishii1, Tsuyoshi Uchiyama1
1Neurology, Seirei Hamamatsu General Hospital, Hamamatsu, JPN.
Abstract:
Neuromyelitis optica spectrum disorder (NMOSD) is an inflammatory disease that causes recurrent neuritis and myelitis. Ravulizumab, a complement protein C5 inhibitor, was developed to treat NMOSD. However, its efficacy in improving symptoms remains unclear. This case report describes the case of a 30-year-old woman with NMOSD who developed thoracic myelitis. Initial treatment with high-dose methylprednisolone and hemodialysis alleviated paraplegia, although urinary retention persisted. Two months after initiating ravulizumab treatment, urinary function improved. Ravulizumab administration may have contributed to the improved urinary retention.
Related Concept Videos
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
Nephrotic Syndrome I : Introduction
Nephrotic Syndrome II : Assessment and Medical Management
Nephrotic Syndrome III : Nursing Management
Urinary Tract Calculi III: Medical Management
Respiratory Syncytial Virus Disease

